Their entire procedure was completed in less than 28 minutes. The current H5N1 tests, on the toehr hand, occur around the space of 4 hours. Their point-of-care tests are comprised of an instrument that has a disposable component and, by being low cost and rapid to use, is ideal for those countries that need it most and where, due to depleted resources, the influenza vaccine is unavailable. Resources for creating their point-of-care tests are inexpensive: a CD-ROM drive, a power supply, a spindle stepper motor for microfluidic actuation, and optics for fluorescence detection. Most countries can, with help from generous and more privileged others, come up with these requirements. Transport and storage related issues would need to be transfigured into the expense.

Conclusion

The authors provide an important and under mentioned perspective to treatment of H5N1 influenza by noting that countries that most need the vaccination and treatment are not receiving it due to their inability to pay for the expense. Bird flue, rather than being impeded, is therefore spreading. The authors, accordingly, posit a supremely practical and professional solution to providing a drug that is not only cheaper, and faster but also as equally effective as standard drugs...

They are certainly important in their contribution to preventing the disease from spreading in developing countries and to impeding it at its outset, but their idea can be applied to developing countries too where a cheaper and more rapid solution will always be welcome. More so, the authors' creation can be applied to a manifold of epidemics that include emerging and re merging infectious diseases such as measles, SARS, HIV / AIDS, hepatitis B, influenza, cholera, tuberculosis, or malaria by extracting nucleic acids from other body fluids such as blood, urine, or salivea. Their contribution, therefore, can be extended to more fields than one and have enormous positive ramifications and impact.
In this way, the authors' contribution has global and far-reaching results and they have reason to believe that the microfluidic system described in their article can be "an attractive diagnostic platform, especially for decentralized environmental, biological, or medical testing" (p.4).

Reference

Pipper, J. et al. (2007) Catching bird flu in a droplet. Nature Medicine;…